Prestige Consumer Healthcare ROA 2010-2024 | PBH
Current and historical return on assets (ROA) values for Prestige Consumer Healthcare (PBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Prestige Consumer Healthcare ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.21B | $3.32B | 6.17% |
| 2024-06-30 | $0.21B | $3.31B | 6.17% |
| 2024-03-31 | $0.21B | $3.32B | 6.27% |
| 2023-12-31 | $-0.08B | $3.34B | -2.42% |
| 2023-09-30 | $-0.08B | $3.33B | -2.38% |
| 2023-06-30 | $-0.09B | $3.35B | -2.41% |
| 2023-03-31 | $-0.08B | $3.35B | -2.30% |
| 2022-12-31 | $0.21B | $3.75B | 5.68% |
| 2022-09-30 | $0.21B | $3.68B | 5.66% |
| 2022-06-30 | $0.20B | $3.68B | 5.50% |
| 2022-03-31 | $0.21B | $3.67B | 5.63% |
| 2021-12-31 | $0.19B | $3.66B | 5.28% |
| 2021-09-30 | $0.18B | $3.68B | 5.09% |
| 2021-06-30 | $0.18B | $3.56B | 5.18% |
| 2021-03-31 | $0.17B | $3.43B | 4.82% |
| 2020-12-31 | $0.17B | $3.47B | 4.82% |
| 2020-09-30 | $0.16B | $3.43B | 4.73% |
| 2020-06-30 | $0.15B | $3.45B | 4.38% |
| 2020-03-31 | $0.14B | $3.51B | 4.09% |
| 2019-12-31 | $-0.03B | $3.46B | -0.98% |
| 2019-09-30 | $-0.03B | $3.47B | -0.97% |
| 2019-06-30 | $-0.04B | $3.46B | -1.01% |
| 2019-03-31 | $-0.04B | $3.44B | -0.99% |
| 2018-12-31 | $0.06B | $3.67B | 1.69% |
| 2018-09-30 | $0.34B | $3.70B | 8.99% |
| 2018-06-30 | $0.34B | $3.77B | 8.87% |
| 2018-03-31 | $0.34B | $3.76B | 8.80% |
| 2017-12-31 | $0.39B | $3.90B | 10.02% |
| 2017-09-30 | $0.11B | $3.90B | 2.97% |
| 2017-06-30 | $0.11B | $3.90B | 3.24% |
| 2017-03-31 | $0.07B | $3.91B | 2.22% |
| 2016-12-31 | $0.07B | $2.81B | 2.51% |
| 2016-09-30 | $0.07B | $2.83B | 2.41% |
| 2016-06-30 | $0.07B | $2.88B | 2.45% |
| 2016-03-31 | $0.10B | $2.95B | 3.69% |
| 2015-12-31 | $0.11B | $2.64B | 4.17% |
| 2015-09-30 | $0.10B | $2.63B | 3.89% |
| 2015-06-30 | $0.09B | $2.64B | 3.26% |
| 2015-03-31 | $0.08B | $2.64B | 3.15% |
| 2014-12-31 | $0.07B | $2.68B | 3.09% |
| 2014-09-30 | $0.05B | $2.73B | 2.52% |
| 2014-06-30 | $0.07B | $1.85B | 3.77% |
| 2014-03-31 | $0.07B | $1.80B | 4.05% |
| 2013-12-31 | $0.08B | $1.87B | 4.25% |
| 2013-09-30 | $0.09B | $1.81B | 4.85% |
| 2013-06-30 | $0.07B | $1.74B | 4.06% |
| 2013-03-31 | $0.07B | $1.74B | 3.71% |
| 2012-12-31 | $0.05B | $1.73B | 2.62% |
| 2012-09-30 | $0.04B | $1.79B | 2.77% |
| 2012-06-30 | $0.04B | $1.75B | 2.71% |
| 2012-03-31 | $0.04B | $1.76B | 3.10% |
| 2011-12-31 | $0.04B | $1.05B | 4.18% |
| 2011-09-30 | $0.04B | $1.06B | 3.42% |
| 2011-06-30 | $0.03B | $1.05B | 3.44% |
| 2011-03-31 | $0.03B | $1.06B | 3.15% |
| 2010-12-31 | $0.03B | $1.05B | 3.05% |
| 2010-09-30 | $0.04B | $0.79B | 4.45% |
| 2010-06-30 | $0.03B | $0.78B | 4.31% |
| 2010-03-31 | $0.03B | $0.79B | 4.03% |
| 2009-12-31 | $-0.18B | $0.79B | -22.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.889B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.127B | 25.27 |
| Stryker (SYK) | United States | $138.991B | 31.32 |
| Boston Scientific (BSX) | United States | $131.097B | 37.69 |
| EssilorLuxottica (ESLOY) | France | $109.895B | 0.00 |
| Medtronic (MDT) | Ireland | $103.904B | 15.43 |
| Haleon (HLN) | United Kingdom | $43.864B | 28.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.859B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.052B | 18.70 |
| ResMed (RMD) | United States | $34.830B | 28.62 |
| Terumo (TRUMY) | Japan | $28.875B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.602B | 18.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.325B | 13.58 |
| Insulet (PODD) | United States | $18.698B | 74.46 |
| Baxter (BAX) | United States | $15.062B | 9.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.781B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.800B | 39.43 |
| Bio-Rad Laboratories (BIO) | United States | $9.168B | 31.16 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.208B | 14.42 |
| ICU Medical (ICUI) | United States | $3.840B | 36.56 |
| Haemonetics (HAE) | United States | $3.789B | 18.49 |
| Perrigo (PRGO) | Ireland | $3.513B | 10.34 |
| Envista Holdings (NVST) | United States | $3.218B | 23.97 |
| QuidelOrtho (QDEL) | United States | $3.016B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.609B | 30.10 |
| LeMaitre Vascular (LMAT) | United States | $2.071B | 50.34 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 29.37 |
| AtriCure (ATRC) | United States | $1.498B | 0.00 |
| InMode (INMD) | Israel | $1.434B | 8.63 |
| AdaptHealth (AHCO) | United States | $1.383B | 9.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.271B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.968B | 0.00 |
| Owens & Minor (OMI) | United States | $0.965B | 7.54 |
| CeriBell (CBLL) | United States | $0.964B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.879B | 15.49 |
| Evolus (EOLS) | United States | $0.690B | 0.00 |
| Omeros (OMER) | United States | $0.597B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.594B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.584B | 25.75 |
| Surmodics (SRDX) | United States | $0.568B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.452B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.439B | 0.00 |
| Quanterix (QTRX) | United States | $0.403B | 0.00 |
| ZimVie (ZIMV) | United States | $0.375B | 31.63 |
| Biote (BTMD) | United States | $0.331B | 7.26 |
| Valneva SE (VALN) | France | $0.324B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.311B | 29.56 |
| Canopy Growth (CGC) | Canada | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
| Zynex (ZYXI) | United States | $0.263B | 55.00 |
| High Tide (HITI) | Canada | $0.242B | 100.33 |
| Aurora Cannabis (ACB) | Canada | $0.234B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 14.29 |
| Sanuwave Health (SNWV) | United States | $0.201B | 2.82 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.190B | 0.00 |
| Brainsway (BWAY) | Israel | $0.174B | 92.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.17 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.81 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Exagen (XGN) | United States | $0.091B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.74 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |